Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells

Author:

Molon Sibilla1,Brun Paola2,Scarpa Melania3,Bizzotto Dario1,Zuccolotto Gaia3,Scarpa Marco4,Fassan Matteo5ORCID,Angriman Imerio4,Rosato Antonio36,Braghetta Paola1,Castagliuolo Ignazio2,Bonaldo Paolo1ORCID

Affiliation:

1. Matrix Biology Unit, Department of Molecular Medicine University of Padova Padova Italy

2. Microbiology Unit, Department of Molecular Medicine University of Padova Padova Italy

3. Istituto Oncologico Veneto (IOV) ‐ IRCCS Padova Italy

4. General Surgery Unit, Department of Surgery, Oncology and Gastroenterology University of Padova Padova Italy

5. Surgical Pathology Unit, Department of Medicine University of Padova Padova Italy

6. Department of Surgery, Oncology and Gastroenterology University of Padova Padova Italy

Abstract

AbstractDespite a number of studies providing evidence that the extracellular matrix (ECM) is an active player in the pathogenesis of intestinal inflammation, knowledge on the actual contribution of specific ECM molecules in the progression of inflammatory bowel disease (IBD) remains scant. Here, we investigated the role of a major ECM protein, collagen VI (ColVI), in gut homeostasis and elucidated the impact of its deregulation on the pathophysiology of IBD. To this end, we combined in vivo and ex vivo studies on wild type and ColVI‐deficient (Col6a1−/−) mice both under physiological conditions and during experimentally induced acute colitis and its subsequent recovery, by means of gut histology and immunostaining, gene expression, bone marrow transplantation, flow cytometry of immune cell subpopulations, and lymph flow assessment. We found that ColVI displayed dynamic expression and ECM deposition during the acute inflammatory and recovery phases of experimentally induced colitis, whereas the genetic ablation of ColVI in Col6a1 null mice impaired the functionality of lymphatic vessels, which in turn affected the resolution of inflammation during colitis. Based on these findings, we investigated ColVI expression and deposition in ileal specimens from two cohorts of patients affected by Crohn's disease (CD) and correlated ColVI abundance to clinical outcome. Our results show that high ColVI immunoreactivity in ileal biopsies of CD patients at diagnosis correlates with increased risk of surgery and that ColVI expression in biopsies taken at the resection margin during surgery, and showing inactive disease, predict disease recurrence. Our data unveil a key role for ColVI in the intestinal microenvironment, where it is involved in lymphangiogenesis and intestinal inflammation. Altogether, these findings point at the dysregulation of ColVI expression as a novel factor contributing to the onset and maintenance of inflammation in CD via mechanisms impinging on the modulation of inflammatory cell recruitment and function. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Funder

Fondazione Cassa di Risparmio di Padova e Rovigo

Fondazione Telethon

Ministero dell'Università e della Ricerca

Publisher

Wiley

Subject

Pathology and Forensic Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3